EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Reduced graphene oxide‐based electrochemically stimulated method for temozolomide delivery

Sathish Reddy, Li Song, Yuyuan Zhao, Rong Zhao, Dongni Wu, Liumin He, Seeram Ramakrishana

MEDICAL DEVICES & SENSORS · 2018

DOI: 10.1002/mds3.10014 ↗
AbstractBibliografische Angaben

Abstract

Abstract The controlled release of drug molecules to a specific brain tumour's tissue has been recognized as one of the most demanding researches for treatment of brain cancer, because it helps to avoid the side effects from systemic drug delivery techniques. In the present work, described an electrochemically controlled drug delivery performed with a reduced graphene oxide (rGO)‐drug composite. The rGO was loaded with a temozolomide ( TMZ ) molecule ( rGO ‐ TMZ ) exhibits electrochemical oxidation and reduction peak in 0.1 M phosphate buffer solution ( pH 7.4). In response to be electrochemical potential, the rGO ‐ TMZ composite releases TMZ drug, and TMZ drug dosage that can be adjusted by altering the electrochemical potential with time. Upon application of an electrochemical potential pulse (0.8 V) for 20 min duration, up to 83% of TMZ was released into citrate buffer solution at pH 5.0. In vitro, cell culture experiments demonstrate that the released TMZ drug retains its bioactivity. The electrochemically controlled rGO‐ TMZ composite drug delivery platform makes it an exciting candidate for on‐demand drug delivery for effective treatment of brain cancer.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →